Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Z59N7 | — |
Boostrix allergic reaction 2 days after the shot; This non-serious case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a adult patient who received DTPa (Reduced antigen) (Boostrix) (batch number Z59N7, expiry date 08-OCT-2022) for prophylaxis. On 15-SEP-2020, the patient received Boostrix. In SEP-2020, 2 days after receiving Boostrix, the patient experienced allergic reaction (Verbatim: Boostrix allergic reaction 2 days after the shot). The outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to Boostrix. It was unknown if the company considered the allergic reaction to be related to Boostrix. Additional Information: GSK receipt Date: 17-SEP-2025 On 15th September 2020 an adult over 50 years not immunocompromised patient received Boostrix in another facility and 2 days later reported allergic reaction.